4.7 Review

Understanding stem cells and its pivotal role in regenerative medicine

Journal

LIFE SCIENCES
Volume 273, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.lfs.2021.119270

Keywords

Stem cell; Signalling pathways; Cell-labelling; Diabetes; Cancer; Cardiovascular disease; Neurological disorders

Funding

  1. All India Council for Technical Education (AICTE), New Delhi, India
  2. RUSA 2.0 of University Grants Commission (UGC), New Delhi
  3. University Grants Commission (UGC), New Delhi, India

Ask authors/readers for more resources

This paragraph emphasizes the importance of stem cells in regenerative medicine, providing information on their classification, differentiation, and various isolation techniques. It also discusses the signaling pathways affecting stem cell regeneration and factors regulating their potency. Additionally, the application of stem cells in clinical fields for treating diseases such as diabetes, cancer, cardiovascular disorders, and neurological disorders is highlighted, along with the biomarkers associated with these conditions.
Stem cells (SCs) are clonogenic cells that develop into the specialized cells which later responsible for making up various types of tissue in the human body. SCs are not only the appropriate source of information for cell division, molecular and cellular processes, and tissue homeostasis but also one of the major putative biological aids to diagnose and cure various degenerative diseases. This study emphasises on various research outputs that occurred in the past two decades. This will give brief information on classification, differentiation, detection, and various isolation techniques of SCs. Here, the various signalling pathways which includes WNT, Sonic hedgehog, Notch, BMI1 and C-met pathways and how does it effect on the regeneration of various classes of SCs and factors that regulates the potency of the SCs are also been discussed. We also focused on the application of SCs in the area of regenerative medicine along with the cellular markers that are useful as salient diagnostic or curative tools or in both, by the process of reprogramming, which includes diabetes, cancer, cardiovascular disorders and neurological disorders. The biomarkers that are mentioned in various literatures and experiments include PDX1, FOXA2, HNF6, and NKX6-1 (for diabetes); CD33, CD24, CD133 (for cancer); c-Kit, SCA-1, Wilm's tumor 1 (for cardiovascular disorders); and OCT4, SOX2, c-MYC, EN1, DAT and VMAT2 (for neurological disorders). In this review, we come to know the advancements and scopes of potential SC-based therapies, its diverse applications in clinical fields that can be helpful in the near future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available